Journal of Multiple Sclerosis and Neuroimmunology

Most download articles

Page Path

HOME
BROWSE ARTICLES
Most download articles

From articles published in J Mult Scler Neuroimmunol during the past two years (2024~ ).

Original Article

National Consensus Guidance for Management of Refractory Myasthenia Gravis (160 times): Hyung-Soo Lee, Hye Yoon Chung, Seung Woo Kim, Eunhee Sohn, Tai-Seung Nam, Kyong Jin Shin, Sa-Yoon Kang, Hyunjin Kim, Jin-Sung Park, Byeol-A Yoon, Hung Youl Seok, Jeong Bin Bong, Yeon-Kyung Jung, Yoon-Ho Hong, Ha Young Shin; J Mult Scler Neuroimmunol. 2024;15(2):59-71. Published online December 31, 2024; DOI: https://doi.org/10.59578/jmsni.2024.15.2.59-71
Cited By 1; Full text PubReader ePub PDF

Review Article

Autoimmune Nodopathy: When to Suspect and How to Treat? (101 times): Young Gi Min, Ha Young Shin, Jung-Joon Sung; J Mult Scler Neuroimmunol. 2024;15(1):23-30. Published online June 30, 2024; DOI: https://doi.org/10.59578/jmsni.2024.15.1.23; Full text PubReader ePub PDF

Original Article

Real-World Epidemiology of Multiple Sclerosis in Korea: Insights from a 2025 Nationwide Hospital-Based Multicenter Study (16 times): Sooyoung Kim, Ho Jin Kim, Jae-Won Hyun, Eun-Jae Lee, Young-Min Lim, Hyunjin Kim, Ju-Hong Min, Byung Joon Kim, Seung Ho Choo, Sung-Min Kim, Dong Seok Ohn, Ha Young Shin, Young Nam Kwon, Seung Woo Kim, Ki Hoon Kim, Jun Soon Kim, Woojun Kim, Tai-Seung Nam, You-Ri Kang, Min Su Park, Eunhee Sohn, Kyong Jin Shin, Byung-Jo Kim, Seol-Hee Baek, Jin-Woo Park, Sun-Young Oh, Young Eun Park, Yoon-Ho Hong, Suk-Won Ahn, Woohee Ju, Jeeyoung Oh, Hye Lim Lee, Tae-Kyeong Lee, Byeong-Jun Jeon, Nam-Hee Kim, Sunyoung Kim, Soonwook Kwon, Byeol-A Yoon, Jong Kuk Kim, Jinseok Park, Jin Myoung Seok, Jeong Bin Bong, Eun Bin Cho, Yoo Hwan Kim, Jong Seok Bae, Seong-il Oh, Sung Sang Yoon, Jiwon Yang, Do-Hyung Kim, Jee Eun Kim, Juhyeon Kim, Hyun-June Shin, Ohyun Kwon, Ahwon Kim, Sa-Yoon Kang, Jung Im Seok, Minsung Kang, Joo Hye Sung, Hung Youl Seok, Jinhong Shin, Jae-Hwan Choi, Dae-Seong Kim, Je Hong Min, In Soo Joo, Jung Min So, Su-Hyun Kim; J Mult Scler Neuroimmunol. 2025;16(2):53-59. Published online December 31, 2025; DOI: https://doi.org/10.59578/jmsni.2025.16.2.53-59; Full text PubReader ePub PDF

Review Article

Diagnosis and Management of Neurological Immune Related Adverse Events (26 times): Jae-Won Hyun; J Mult Scler Neuroimmunol. 2025;16(1):1-7. Published online June 30, 2025; DOI: https://doi.org/10.59578/jmsni.2025.16.1.1-7; Full text PubReader ePub PDF

Review Article

Collaboration between Medical Association and Patient Organizations to Overcome Rare Neurological Disorders (25 times): Ki Hoon Kim, Young Nam Kwon, Jun-Soon Kim, Sooyoung Kim, Seung Woo Kim, Kee Hong Park, Jin-Sung Park, Jeong Bin Bong, Jin Myoung Seok, Hung Youl Seok, Hye Lim Lee, Eunbin Cho, Byeoung-Jun Jeon, Seong-il Oh, Public Relations Committee of Korean Society for Neuroimmunology; J Mult Scler Neuroimmunol. 2025;16(1):8-18. Published online June 30, 2025; DOI: https://doi.org/10.59578/jmsni.2025.16.1.8-18; Full text PubReader ePub PDF

Review Article

Eculizumab Therapy in Neuromyelitis Optica Spectrum Disorder (46 times): Jee Eun Kim, Suk-Won Ahn; J Mult Scler Neuroimmunol. 2024;15(2):43-48. Published online December 31, 2024; DOI: https://doi.org/10.59578/jmsni.2024.15.2.43-48; Full text PubReader ePub PDF

Case Report

A Case Report of MOG Antibody-Associated Disease (MOGAD) with Isolated Brainstem and Spinal Cord Involvement (25 times): Ye Lin Kim, Juhee Chae, Sun-Young Oh; J Mult Scler Neuroimmunol. 2024;15(2):81-84. Published online December 31, 2024; DOI: https://doi.org/10.59578/jmsni.2024.15.2.81-84; Full text PubReader ePub PDF

Review Article

The Clinical Utility of the Ocrelizumab for the Patients with Multiple Sclerorsis (37 times): Suk-Won Ahn; J Mult Scler Neuroimmunol. 2024;15(2):49-54. Published online December 31, 2024; DOI: https://doi.org/10.59578/jmsni.2024.15.2.49-54; Full text PubReader ePub PDF

Original Article

Temporal Association between Thymoma Recurrence and Exacerbation of Myasthenia Gravis (30 times): Byeong Cheol Oh, Ha Young Shin, Young Ho Yang, Seung Woo Kim; J Mult Scler Neuroimmunol. 2024;15(2):72-80. Published online December 31, 2024; DOI: https://doi.org/10.59578/jmsni.2024.15.2.72-80; Full text PubReader ePub PDF Supplementary Material

Review Article

Cognitive Dysfunction and Assessment in Multiple Sclerosis (9 times): Eun Oh, Seong-il Oh; J Mult Scler Neuroimmunol. 2025;16(2):35-44. Published online December 31, 2025; DOI: https://doi.org/10.59578/jmsni.2025.16.2.35-44; Full text PubReader ePub PDF

Review Article

Imaging Biomarkers for Differential Diagnosis of Central Nervous System Inflammatory Diseases (40 times): Soonwook Kwon; J Mult Scler Neuroimmunol. 2024;15(1):7-16. Published online June 30, 2024; DOI: https://doi.org/10.59578/jmsni.2024.15.1.7; Full text PubReader ePub PDF

Review Article

Monoclonal Antibody Treatment for Relapse Prevention in Neuromyelitis Optica Spectrum Disorder (40 times): Jae-Won Hyun; J Mult Scler Neuroimmunol. 2024;15(1):17-22. Published online June 30, 2024; DOI: https://doi.org/10.59578/jmsni.2024.15.1.17; Full text PubReader ePub PDF

Case Report

Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder Triggered by Herpes Zoster: A Case Report and Literature Review (8 times): Daecheol Moon, Dong Kyu Kim, Seong-il Oh; J Mult Scler Neuroimmunol. 2025;16(2):60-65. Published online December 31, 2025; DOI: https://doi.org/10.59578/jmsni.2025.16.2.60-65; Full text PubReader ePub PDF

Review Article

Disability Measurement in Multiple Sclerosis: Beyond EDSS (8 times): You-Ri Kang, Tai-Seung Nam; J Mult Scler Neuroimmunol. 2025;16(2):45-52. Published online December 31, 2025; DOI: https://doi.org/10.59578/jmsni.2025.16.2.45-52; Full text PubReader ePub PDF

Review Article

Summary of Cladribine (from Development to Clinical and Practical Treatment) (29 times): Kyong Jin Shin; J Mult Scler Neuroimmunol. 2024;15(2):55-58. Published online December 31, 2024; DOI: https://doi.org/10.59578/jmsni.2024.15.2.55-58; Full text PubReader ePub PDF

Neuroimage

Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease Presenting as a Diffuse Pachymeningitis (27 times): Jun-Soon Kim; J Mult Scler Neuroimmunol. 2024;15(2):85-86. Published online December 31, 2024; DOI: https://doi.org/10.59578/jmsni.2024.15.2.85-86
Cited By 1; Full text PubReader ePub PDF

Case Report

Clinical Manifestation and Prognosis of Overlapping Acute Motor Axonal Neuropathy and Acute Transverse Myelitis with Anti-GM1 and Anti-GD1a Antibodies: A Case Study (14 times): A Young Kim, Hong Keun Yoo, Jong Hyun Jeon, Hyuk Sung Kwon; J Mult Scler Neuroimmunol. 2025;16(1):26-32. Published online June 30, 2025; DOI: https://doi.org/10.59578/jmsni.2025.16.1.26-32; Full text PubReader ePub PDF

Review Article

Clinicoradiological Factors for Predicting and Monitoring the Progression of Multiple Sclerosis (51 times): Jiwon Yang; J Mult Scler Neuroimmunol. 2024;15(1):1-6. Published online June 30, 2024; DOI: https://doi.org/10.59578/jmsni.2024.15.1.1; Full text PubReader ePub PDF Supplementary Material

Case Report

Severe Neutropenia Following Rituximab Treatment in Patients with Multiple Sclerosis (25 times): Ki Hoon Kim, Su-Hyun Kim, Jae-Won Hyun, Ho Jin Kim; J Mult Scler Neuroimmunol. 2024;15(1):31-34. Published online June 30, 2024; DOI: https://doi.org/10.59578/jmsni.2024.15.1.31; Full text PubReader ePub PDF

Original Article

Ocrelizumab's Place in the Therapeutic Landscape at its 2019 Launch in France (14 times): Grégoire Mercier, David Pau, Guillaume Bourel, Manon Belhassen, Floriane Deygas, Clarisse Marchal, Sophie Larrieu, Alexandre Civet, Xavier Moisset; J Mult Scler Neuroimmunol. 2025;16(1):19-25. Published online June 30, 2025; DOI: https://doi.org/10.59578/jmsni.2025.16.1.19-25; Full text PubReader ePub PDF Supplementary Material

Volume 16, No. 2

Journal of Multiple
Sclerosis and
Neuroimmunology

Print ISSN: 2733-8290
Online ISSN: 2951-2972

MOST VIEWED MOST CITED

3,349	Autoimmune Nodopathy: When to Suspect and How to Treat?
3,015	National Consensus Guidance for Management of Refractory Myasthenia Gravis
2,107	Monoclonal Antibody Treatment for Relapse Prevention in Neuromyelitis Optica Spectrum Disorder
1,955	Clinicoradiological Factors for Predicting and Monitoring the Progression of Multiple Sclerosis
1,515	Severe Neutropenia Following Rituximab Treatment in Patients with Multiple Sclerosis

Cited By 1	National Consensus Guidance for Management of Refractory Myasthenia Gravis
Cited By 1	Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease Presenting as a Diffuse Pachymeningitis

Editorial Office: Department of Neurology, Chung-Ang University Hospital, Chung-Ang University College of Medicine 102, Heukseok-ro, Dongjak-gu, Seoul 06973, Korea
Tel: +82-2-6299-3153 E-mail: jmsni@koreams.org

Copyright © 2026 by Korean Society of Neuroimmunology.